Article
Enhanced Side Effect Management Program Highlights Specialty Week in Review
Author(s):
Top stories of the week on Specialty Pharmacy Times from June 8-12.
Top stories of the week on Specialty Pharmacy Times from June 8-12.
Medicare Costs on the Rise for Older Oral Cancer Patients
Costs grow for people with oral cavity and pharyngeal cancers based on demographics, co-existing illnesses, and treatment selection.
http://www.specialtypharmacytimes.com/news/Medicare-Costs-on-the-Rise-for-Older-Oral-Cancer-Patients
Overhaul of Hepatitis C Screening Needed
Comprehensive screening guidelines needed for populations with multiple risk factors.
http://www.specialtypharmacytimes.com/news/Overhaul-of-Hepatitis-C-Screening-Needed
Improved Side Effect Management May Help Cancer Patients Remain on Therapy
Undertreated side effects in treatment of some colon and stomach cancers need to be addressed.
Gene Therapy With Herpes Virus Extends Survival in Advanced Brain Cancer Patients
Glioblastoma treatment with surgical resection may benefit patients with worst prognoses.
Multiple Myeloma Biologic Seeks FDA Approval
Drug is being evaluated for the treatment of patients who received at least 3 prior lines of therapy.
http://www.specialtypharmacytimes.com/news/Multiple-Myeloma-Biologic-Seeks-FDA-Approval
Overcoming Specialty Drug Cost Challenges
David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, Inc, discusses methods to address the growing cost of specialty medications.
http://www.specialtypharmacytimes.com/videos/Overcoming-Specialty-Drug-Cost-Challenges
Variant Makes Chemotherapy Preferred Option for Some Advanced Prostate Cancer Patients
Men with AR-V7 variant more likely to be resistant to hormone drugs.
Specialty Pharmacy Makes Inroads in Urology Practice
Increasing number of urology practices working with specialty pharmacies.
http://www.specialtypharmacytimes.com/news/Specialty-Pharmacy-Makes-Inroads-in-Urology-Practice
Rare Blood Disorder Drug Approved for Kids
Promacta is the first and only oral thrombopoietin-receptor agonist that increases platelet production.
http://www.specialtypharmacytimes.com/news/Rare-Blood-Disorder-Drug-Approved-for-Kids
Early Quality of Life Care Lowers Overall Cancer Treatment Costs
Early palliative care reduces costs more than traditional treatment standards.
HIV-Infected Transgender Women Less Adherent to Medications
Study finds greater unmet needs for basic services compared with male patients.
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa
